Music vs Midazolam During Preop Nerve Block Placement

September 9, 2019 updated by: University of Pennsylvania

Music vs Midazolam During Preoperative Nerve Block Placement: A Prospective, Randomized Controlled Study

The purpose of this study is to determine if there are differences in anxiety scores, heart rate, blood pressure, and oxygen status when using sedation medication versus music while undergoing a peripheral nerve block before your surgery.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The general flow of the study will be conducted as follows:

  1. Research coordinator will call or approach patients who are scheduled for a surgical procedure that is planning for a peripheral nerve block either for the primary anesthetic or for postoperative pain control to be placed in the preoperative bay in the ambulatory surgical center.
  2. Research coordinator will discuss the purpose of our study and explain the study in detail for the patient. If a patient agrees to participate, then we will have the patient sign the informed consent for the study. If patient is on the phone and decides to participate, the patient will sign the informed consent upon arriving to Penn Medicine University City (PMUC).
  3. Once the patient signs the informed consent for the peripheral nerve block by anesthesia team. The patient randomized will be revealed to either music or IV midazolam. The pre-procedure anxiety score will then be obtained using the STAI-6 validated tool.
  4. The golden moment will be conducted between the patient, provider, and nursing staff. Once this golden moment is completed, the anxiolytic intervention will start (music or IV midazolam)*
  5. The preoperative nerve block will be conducted by the regional anesthesia block team.
  6. Once the nerve block is complete, we will obtain the post-procedure anxiety score using the STAI-6 validated tool.
  7. Once the post-procedure anxiety score has been obtained, we will also obtain the patient satisfaction score, the provider satisfaction score, and the evaluation of any difficulties in communication between the provider and patient. After these questions have been obtained, the study is complete.

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • University of Pennsylvania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients who are >18 years of age, who will give informed consent in receiving a peripheral nerve block in the preoperative bay for their primary anesthetic and/or for their postoperative pain control.

Exclusion Criteria:

  • significant psychiatric disorder such as generalized anxiety disorder, panic disorder, depression, psychosis, bipolar disorder; individuals who were incompetent to give informed consent; pregnant and/or breast feeding patients; any underlying coagulopathy, infection or other factors which would be a contraindication to receiving a peripheral nerve block; hypersensitivity to midazolam; and history of renal impairment. Patients who were extremely anxious (scores 50 and greater on the State Trait Anxiety Inventory-6 (STAI-6) tool) were also excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Midazolam group
IV midazolam (1mg to 2mg max)
patients in this group will receive IV midazolam (1mg to 2mg max) after the golden moment has been completed
Other Names:
  • Hypnovel
Active Comparator: Music group
research-selected music
patients in this group will receive research-selected music after the golden moment has been completed between the patient, provider, and nursing staff

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety Levels
Time Frame: 1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after)

Spielberger State-Trait Anxiety Inventory 6

Scale range is from 20 to 80. Higher the score, the higher the anxiety level is.

1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after)
Change in STAI-6 Scores From Post to Pre.
Time Frame: 1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after)

Spielberger State-Trait Anxiety Inventory 6

Scale range is from 20 to 80. Higher the score, the higher the anxiety level is.

1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Satisfaction Scores of the Experience During Procedure
Time Frame: immediately after nerve block placement (less than 1 minute after)

survey which assess satisfaction on a 10-point numeric rating scale

Scale ranges from 0 to 10. A higher number indicates a higher satisfaction

immediately after nerve block placement (less than 1 minute after)
Provider Satisfaction Scores of the Experience During Procedure
Time Frame: immediately after nerve block placement (less than 1 minute after)

survey which assess satisfaction on a 10-point numeric rating scale

Scale ranges from 0 to 10. A higher number indicates a higher satisfaction

immediately after nerve block placement (less than 1 minute after)
Evaluation of Difficulties in Communication From Provider to Patient and Patient to Provider
Time Frame: immediately after nerve block placement (less than 1 minute after)

surveyed on a 5-point Likert scale

Scale ranges from 1 to 5; the higher the number, the more difficult it is to communicate.

immediately after nerve block placement (less than 1 minute after)
Block Times
Time Frame: immediately after nerve block placement (less than 1 minute after)
differences amongst music and midaz group
immediately after nerve block placement (less than 1 minute after)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Veena Graff, MD, MS, University of Pennsylvania, Anesthesia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 12, 2017

Primary Completion (Actual)

May 11, 2018

Study Completion (Actual)

May 11, 2018

Study Registration Dates

First Submitted

February 22, 2017

First Submitted That Met QC Criteria

February 27, 2017

First Posted (Actual)

March 3, 2017

Study Record Updates

Last Update Posted (Actual)

September 10, 2019

Last Update Submitted That Met QC Criteria

September 9, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on Midazolam

3
Subscribe